UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in IOVA — Iovance Biotherapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in IOVA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,664,084
+$381,790 QoQ
Shares Held
474,099
+0.9% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 38.240747185714376.ToString("F0")%
Shared 0.ToString("F0")%
None 61.759252814285624.ToString("F0")%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. IOVA ranks #110 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in IOVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,664,084 | 474,099 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,282,294 | 469,706 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,045,462 | 481,781 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,130,397 | 657,209 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $19,238,551 | 5,777,344 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $14,117,177 | 1,907,727 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $18,280,844 | 1,946,842 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $15,995,886 | 1,994,500 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,665,375 | 179,850 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,462,561 | 179,897 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $826,560 | 181,662 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $902,321 | 128,171 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $783,123 | 128,171 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $819,010 | 128,171 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,227,876 | 128,171 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,731,147 | 156,807 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,621,956 | 217,535 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,399,181 | 178,061 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,296,434 | 174,227 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,577,200 | 175,911 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $9,814,565 | 309,999 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $14,411,281 | 310,588 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $9,548,673 | 290,057 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,962,474 | 290,072 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,878,859 | 263,155 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||